Grifols (GIFLF) Divestments (2012 - 2025)
Grifols' (GIFLF) quarterly Divestments came in at -$125.7 million in Q4 2025, up 58.86% on a YoY basis from -$79.1 million in Q4 2024, and up 58.86% quarter-over-quarter from -$305.6 million in Q4 2024.
Analysis
Grifols (GIFLF) Divestments (2012 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Divestments for 8 consecutive years, with -$125.7 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Divestments rose 58.86% year-over-year to -$125.7 million; the trailing twelve-month figure through Dec 2025 stood at -$2.0 billion (down 3.06% YoY), and the FY2025 full-year result was -$122.0 million, up 60.07% from the prior year.
- Divestments climbed to -$125.7 million in Q4 2025 per GIFLF's latest filing, from -$305.6 million in the prior quarter.
- Across five years, Divestments topped out at -$31.2 million in Q4 2023 and bottomed at -$1.6 billion in Q4 2022.
- Historically, Divestments has averaged -$506.7 million across 4 years, with a median of -$215.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Divestments surged 98.01% in 2023, then sank 879.47% in 2024.
- Over 4 years, Divestments stood at -$1.6 billion in 2022, then soared by 98.01% to -$31.2 million in 2023, then plunged by 879.47% to -$305.6 million in 2024, then surged by 58.86% to -$125.7 million in 2025.
- According to Business Quant data, Divestments over the past three periods registered -$125.7 million, -$305.6 million, and -$31.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | -125.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -125.72 Mn |
| Dec 31, 2024 | -305.62 Mn |
| Dec 31, 2023 | -31.20 Mn |
| Dec 31, 2022 | -1.56 Bn |
| Mar 31, 2015 | -65.58 Mn |
| Mar 31, 2014 | 1.66 Bn |
| Dec 31, 2013 | -18.48 Mn |
| Sep 30, 2013 | -25.84 Mn |
| Dec 31, 2012 | 2.50 Mn |
| Sep 30, 2012 | 1.88 Mn |